MIKADO: a multicentre, open‐label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine

C. Katlama,J. Pellegrin,D. Lacoste,C. Aquilina,F. Raffi,G. Pialoux,D. Vittecoq,G. Raguin,O. Lantz,M. Mouroux,V. Calvez,A. Trylesinski,F. Montestruc,E. Dohin,Jm Goehrs
DOI: https://doi.org/10.1046/j.1468-1293.2001.00046.x
2001-01-01
HIV Medicine
Abstract:Background  Since eradication of HIV is unlikely, long‐term management of the disease necessitates careful evaluation of the combinations of currently available drugs to determine the most potent and useful rational sequencing of regimens.
What problem does this paper attempt to address?